What does CUSIP 62818Q203 represent in this 13F holders report?

CUSIP 62818Q203 is the security identifier for MBIO - Mustang Bio, Inc. - Common Stock, $0.0001 Par Value used to aggregate holder disclosures.

How many institutions held MBIO - Mustang Bio, Inc. - Common Stock, $0.0001 Par Value in Q4 2024?

28 institutional investors reported MBIO - Mustang Bio, Inc. - Common Stock, $0.0001 Par Value for Q4 2024. Use the holders table for investor-level position and value details.

Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (MBIO)

CUSIP: 62818Q203

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class: Equity / Common Stock, $0.0001 Par Value
Total 13F shares: 4,670,658
Total 13F value: $826,515
Share change: +3,778,019
SEC-reported price per share: $0.18
Number of holders: 28
Value change: +$649,537
Number of buys: 14
Number of sells: 8
Shares outstanding: 52,979,435

Security key

62818Q203

Report period

Q4 2024

Institutions

Top holders

MBIO full security history Ownership snapshot Full 13F holder table MUSTANG BIO, INC. SEC filings MUSTANG BIO, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MBIO - Mustang Bio, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Fortress Biotech, Inc.

Disclosed value leader

Fortress Biotech, Inc.

Comparable rows

1/15

Latest evidence

31 Dec 2024

13D/G 3/4/5 13F Lead comparable stake: 12% 14 rows are not safely comparable across share classes. 13D/G row: Fortress Biotech, Inc. Showing 1-6 of 15 holder rows.

Quick read

Fortress Biotech, Inc. leads the comparable SEC ownership view at 12%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Fortress Biotech, Inc.'s linked filing trail.

Comparable ownership Top 1

Fortress Biotech, Inc. 12%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Fortress Biotech, Inc.	13D/G 13D/G	12% Reported 13D/G · 31 Dec 2024	$1,708,057 6,569,450 shares	$0	31 Dec 2024
Brian Achenbach	3/4/5 SVP, Fin. & Corp. Controller 3/4/5	— denominator unverified	$74,738 144,729 shares	—	08 Dec 2021
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$57,764 245,486 shares	—	30 Sep 2024
Lindsay A. Rosenwald MD	3/4/5 Director 3/4/5	— denominator unverified	$31,255 60,525 shares	—	05 Jul 2023
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$26,535 112,773 shares	—	30 Sep 2024
Michael S. Weiss	3/4/5 Director 3/4/5	— denominator unverified	$25,633 49,637 shares	—	05 Jul 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

4,670,658

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders

Q4 2024 holders

Holder diff

Investor	Q3 2024 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q3 2024 value	Q4 2024 value	Value change	Value Chg %